ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

ClinicalTrials.gov ID: NCT07290036

Public ClinicalTrials.gov record NCT07290036. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 7:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Parallel-group, Noninferiority Study to Evaluate the Pharmacokinetics of Bimekizumab Administered Intravenously or as a Subcutaneous Injection in Participants With Active Psoriatic Arthritis and/or Active Axial Spondyloarthritis

Study identification

NCT ID
NCT07290036
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
UCB Biopharma SRL
Industry
Enrollment
392 participants

Conditions and interventions

Interventions

  • Bimekizumab regimen 1 iv Drug
  • Bimekizumab regimen 2 iv Drug
  • Bimekizumab regimen 3 sc Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 9, 2025
Primary completion
May 17, 2028
Completion
Sep 13, 2028
Last update posted
May 7, 2026

2025 – 2028

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Pa0019 114 Peoria Arizona 85381-5025 Recruiting
Pa0019 127 Apple Valley California 92307 Recruiting
Pa0019 111 Covina California 91722 Recruiting
Pa0019 117 Riverside California 92518 Recruiting
Pa0019 125 San Leandro California 94578 Recruiting
Pa0019 126 Temecula California 92592 Recruiting
Pa0019 141 Upland California 91786 Recruiting
Pa0019 120 Whittier California 90602 Recruiting
Pa0019 128 Whittier California 90602 Recruiting
Pa0019 123 Fort Collins Colorado 80528 Recruiting
Pa0019 143 Ormond Beach Florida 32174 Recruiting
Pa0019 113 South Miami Florida 33155 Recruiting
Pa0019 132 Chicago Illinois 60661 Recruiting
Pa0019 134 Lansing Michigan 48911 Recruiting
Pa0019 140 West Long Branch New Jersey 07764-1503 Recruiting
Pa0019 131 Albuquerque New Mexico 87102 Recruiting
Pa0019 115 Duncansville Pennsylvania 16635 Recruiting
Pa0019 142 Rock Hill South Carolina 29732 Recruiting
Pa0019 116 Jackson Tennessee 38305 Recruiting
Pa0019 138 Murfreesboro Tennessee 37128 Recruiting
Pa0019 129 Baytown Texas 77521 Recruiting
Pa0019 136 Colleyville Texas 76034 Recruiting
Pa0019 135 Mesquite Texas 75150 Recruiting
Pa0019 124 Plano Texas 75075 Recruiting
Pa0019 121 Bellevue Washington 98004 Recruiting
Pa0019 145 Spokane Washington 99216 Recruiting
Pa0019 130 Beckley West Virginia 25801 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07290036, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07290036 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →